Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Releases More Health-Reform Guidelines, But Drug System Delayed

This article was originally published in PharmAsia News

Executive Summary

China's State Council issued additional guidelines of its long-delayed health care reform plan, including a delay in the release of a basic-drugs catalogue until the end of the year. The catalogue is part of a system for pharmaceuticals, also delayed until the end of the year, intended to be implemented in 30 percent of the nation's community clinics and county-level clinics. It already had been disclosed the catalogue drugs would be produced and distributed under government control. The drugs would be covered by medical insurance, requiring another special administration to be established. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts